April 2024
1. ZHANG P, Fleming P, Andoniou CE, Waltner OG, et al
   IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation.
   J Clin Invest. 2024;134:e174184.
   

   >> Share

   
   August 2023
2. LI Q, Wang X, Song Q, Yang S, et al
   Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity.
   J Clin Invest. 2023;133:e165723.
   

   >> Share

   
   
3. LOGAN BR, Fu D, Howard A, Fei M, et al
   Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
   J Clin Invest. 2023;133:e168575.
   

   >> Share

   
   November 2022
4. LU C, Ma H, Song L, Wang H, et al
   IFNGR/STAT1 signaling in recipient hematopoietic antigen presenting cells suppresses graft-versus-host disease.
   J Clin Invest. 2022 Nov 29:e125986. doi: 10.1172/JCI125986.
   

   >> Share

   
   May 2022
5. KTENA YP, Koldobskiy MA, Barbato MI, Fu HH, et al
   Donor T-cell DNMT3a regulates alloreactivity in murine models of hematopoietic stem cell transplantation.
   J Clin Invest. 2022 May 24. pii: 158047. doi: 10.1172/JCI158047.
   

   >> Share

   
   
6. DWYER GK, Mathews LR, Villegas JA, Lucas A, et al
   IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.
   J Clin Invest. 2022 May 3. pii: 150927. doi: 10.1172/JCI150927.
   

   >> Share

   
   August 2020
7. LIU Y, Wang X, Zhu Y, Zhang M, et al
   Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice.
   J Clin Invest. 2020 Aug 20. pii: 131799. doi: 10.1172/JCI131799.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share